Tempus AI company profile

TEM · NASDAQ · USD

Compare Tempus AI
$63.43Change from previous close: −2.05%Absolute change: −$1.33

Close · November 17, 2026

Company profile

Tempus AI has 3,800 employees and is headquartered in Chicago, United States.

With revenue of $1.3 billion in the fiscal year ended December 2025, Tempus AI operates its Tempus platform, which links clinician workflows with laboratory diagnostics, analytics and a repository of multimodal data. Its diagnostic offering includes next-generation sequencing tests, large-panel solid tumor and hematologic assays, pharmacogenomic testing for psychiatric conditions and genetic tests for inherited conditions. The group also licenses de-identified clinical, molecular and imaging datasets, offers clinical trial matching and develops software such as Lens, Next and Algos for life sciences research and diagnostics. Its customers include physicians and healthcare providers, and its strategic collaborations include AstraZeneca, GlaxoSmithKline, Merck, Recursion Pharmaceuticals and Blood Cancer United, the latter on a pediatric acute myeloid leukemia registry. Its operations are in the United States.

Revenue rose 83.4% from the prior year, and the company reported a net loss of $245.0 million for the fiscal year ended December 2025. It has 3,800 employees and is based in Chicago, Illinois. Founded in 2015, the company was formerly known as Tempus Labs, Inc. and adopted its current name in January 2023.

Company facts

Industry
Health Information Services
Headquarters
600 West Chicago Avenue, 60654, Chicago
Employees
3,800
Chief executive
Eric Lefkofsky
Founded
2015
Fiscal year
January - December
Listing
TEM · NASDAQ
Currency
USD
ISIN
US88023B1035
Website
tempus.com

Tempus AI and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Tempus AITEMUnited States$11.81B3,800-18.5%—
DoximityDOCSUnited States$5.85B88027.1%45.5
Veeva SystemsVEEVUnited States$48.46B7,92829.9%49.1
Pro MedicusPMEAustralia$14.19B15374.9%79.4
M32413Japan$7.64B17,01019.5%26.5
XtalPi Holdings2228Hong Kong SAR China$3B1,623-124.6%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Tempus AI with its competitors